SCD patient groups evaluated
| Group 1 (n = 19) | Low levels of both PS+ and CD36+ erythrocytes |
| Group 2 (n = 45) | Elevated levels of both PS+ and CD36+erythrocytes |
| Group 3 (n = 10) | Low levels of erythrocyte PS in combination with elevated CD36 levels |
| Group 4 (n = 13) | Elevated levels of erythrocyte PS in combination with low CD36 levels |
| Group 1 (n = 19) | Low levels of both PS+ and CD36+ erythrocytes |
| Group 2 (n = 45) | Elevated levels of both PS+ and CD36+erythrocytes |
| Group 3 (n = 10) | Low levels of erythrocyte PS in combination with elevated CD36 levels |
| Group 4 (n = 13) | Elevated levels of erythrocyte PS in combination with low CD36 levels |
Levels of erythrocyte PS and CD36 were considered elevated if the values were more than 3 SD above that seen in the control population, that is, 2.5% and 0.4% for PS and CD36, respectively.